ImmuPharma (LON:IMM) Trading Up 15.4% – Here’s What Happened

ImmuPharma plc (LON:IMMGet Free Report) shares shot up 15.4% during trading on Friday . The company traded as high as GBX 4.79 ($0.06) and last traded at GBX 4.50 ($0.06). 5,421,370 shares changed hands during mid-day trading, a decline of 75% from the average session volume of 21,306,619 shares. The stock had previously closed at GBX 3.90 ($0.05).

ImmuPharma Stock Up 25.1 %

The stock has a market capitalization of £20.32 million, a P/E ratio of -488.00 and a beta of 1.53. The firm has a fifty day moving average price of GBX 2.39 and a two-hundred day moving average price of GBX 1.93.

ImmuPharma Company Profile

(Get Free Report)

ImmuPharma PLC (LSE AIM: IMM) is a specialty biopharmaceutical company that discovers and develops peptide-based therapeutics. The Company’s portfolio includes novel peptide therapeutics for autoimmune diseases and anti-infectives. The lead program, P140 (Lupuzorâ„¢), is a first-in class autophagy immunomodulator for the treatment of Lupus and preclinical analysis suggest therapeutic activity for many other autoimmune diseases that share the same autophagy mechanism of action.

See Also

Receive News & Ratings for ImmuPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmuPharma and related companies with MarketBeat.com's FREE daily email newsletter.